SCHEMBL23134243

SCHEMBL23134243

CCC(NC)c1ccc2c(c1)CCCC2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.40
HSP90AA1 P07900 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.40
KEAP1 Q14145 8/20 0.39
NFE2L2 Q16236 8/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
SCN1A P35498 1/20 0.39
SCN5A Q14524 1/20 0.39
SCN8A Q9UQD0 1/20 0.39
CYP3A4 P08684 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 1/20 0.36
ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28830779 0.78 NPC1 (0.41) ALDH1A1KMT2AHTTHSP90AA1GAA
SCHEMBL8285021 0.77 ALDH1A1 (0.52) ALDH1A1KMT2AHTTHSP90AA1GAA
SCHEMBL24023602 0.77 ALDH1A1 (0.44) ALDH1A1KMT2AHTTHSP90AA1GAA
SCHEMBL20238711 0.75 SLC6A4 (0.43) ALDH1A1KMT2AHTTHSP90AA1GAA
SCHEMBL765609 0.73 ALDH1A1 (0.49) ALDH1A1KMT2AHTTHSP90AA1GAA
SCHEMBL9859659 0.71 KMT2A (0.46) ALDH1A1KMT2AHTTHSP90AA1GAA
SCHEMBL8285901 0.71 SMN1; SMN2 (0.35) ALDH1A1LMNA
SCHEMBL8285916 0.70 L3MBTL1 (0.47) ALDH1A1KMT2AMEN1LMNA
SCHEMBL13096521 0.70 L3MBTL1 (0.47) ALDH1A1KMT2AMEN1LMNA
Butidrine SCHEMBL6510088 0.69 ADRB2 (0.47) ALDH1A1KMT2AGAAMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021055326-A1 AZOLE-FUSED PYRIDAZIN-3(2H)-ONE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-03-25 WO disclosed